Goldman Sachs Maintains Neutral on RXO, Raises Price Target to $20

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE: RXO) with a Neutral and raises the price target from $18 to $20.